Loading card…

Cynde Carpenter

Cynde Carpenter

The New Health Conversation®️ reveals new studies showing that the loss of lean muscle mass is a risk factor for dementia and Alzheimer's.

Important Note: These studies did not in any way imply that losing lean muscle mass is the cause of dementia or Alzheimer's. They simply identified it as a substantial risk factor.

The Hidden Cost of Weight Loss
Based on medical studies, nearly every diet or GLP-1 results in a loss of twenty-five to forty percent lean muscle mass.

What New Published Research Shows Is Possible
Ten independent, published, peer-reviewed human trial studies on Protein Pacing®️ and Intermittent Nutritional Fasting®️ (R2M Protocol), conducted by Dr. Paul Arciero and his team of nutritional and weight loss researchers at Skidmore College in New York — he was just awarded the Excellence in Nutrition Fellow from the American Society of Nutrition, the highest honor in nutritional research globally — where everyone in the studies, including people in their sixties, gained a six to fifteen percent proportion of overall lean muscle.

Note: No one in these studies was allowed to exercise. Not a single participant.

What the New Studies on Dementia and Alzheimer's Found (Note: These studies were not conducted by Dr. Paul Arciero's team)

These new studies tracked real people—not animals—over years and counted who actually developed dementia and Alzheimer's.

Korean National Health Insurance Study on Dementia
Followed twelve point three million people for eight years. The loss of muscle mass in the arms and legs raised the risk of dementia by thirty percent. And the same study found that a modest increase in lean muscle lowered the risk of dementia by thirty percent.

Johns Hopkins University Study on Alzheimer's
Studied six hundred twenty-one older adults for nearly six years and found that a decrease in the overall proportion of skeletal lean muscle mass (not just in the arms and legs) was tied to a sixty percent higher risk of Alzheimer's — the less muscle people had, the higher their risk climbed.

UK Biobank Study on Alzheimer's
Studied four hundred fifty thousand participants and found that a modest increase in lean muscle lowered the risk of Alzheimer's by twelve percent.

Why Losing Lean Muscle Mass Is So Unhealthy
In addition to the increased risk of dementia and Alzheimer's, losing lean muscle mass also lowers your metabolism, weakens your immune system, and raises your risk of insulin resistance and pre-diabetes. Nearly every diet or GLP-1, in studies, showed a loss of twenty-five to forty percent of your lean muscle.

The Maintenance Imperative
One of the main reasons you'd want to do Protein Pacing®️ and Intermittent Nutritional Fasting®️ (R2M Protocol) for the rest of your life, certainly as a maintenance program, is to do everything possible to maintain your overall lean muscle mass. It is not a weight loss program. It is an overall health program. Hopefully you can see the benefit of being on this for maintenance.
According to Dr. Arciero: The Most Important Reason to Do the R2M Protocol Is Maintenance — Not Optional, It's Mandatory

Being on Protein Pacing®️ and Intermittent Nutritional Fasting®️ (R2M Protocol) for the rest of your life is not optional — it's mandatory if you want to do everything possible to age gracefully. He went on to say that adding creatine to your daily maintenance can substantially increase your ability to age gracefully. The studies on creatine and its potential role in dementia and Alzheimer's — which he discusses in the attached video — are something you would definitely want to review as well.

Use Your Own Common Sense
Based on the new studies on risk factors, use your own common sense: is gaining six to fifteen percent lean muscle mass likely healthier than losing twenty-five to forty percent on diets or GLP-1s? We're not making that claim — you decide.

Protein Pacing®️ and Intermittent Nutritional Fasting®️ (R2M Protocol) are not intended to cure, treat, diagnose, or prevent any medical conditions. These statements have not been evaluated by the FDA.